Max Robotics — Global Service Robot Directory + US Certification

About

Ruriko Honda‐Takinami is a leading urological surgeon and researcher whose work focuses on improving functional outcomes and quality of life for prostate cancer patients undergoing robot-assisted radical prostatectomy (RARP). Her research centers on three key areas: postoperative urinary continence, detrusor function, and patient-reported satisfaction. In her landmark 2021 prospective study (11 citations), she identified the prevalence and predictors of postoperative detrusor underactivity, a critical but often overlooked complication. Her 2023 work (7 citations) made a significant contribution by elucidating the role of the puboperinealis and rectourethralis muscles as a urethral support system essential for maintaining continence after RARP. More recently, she has investigated longitudinal changes in patient satisfaction using validated questionnaires (2025) and identified three predictive markers for de novo overactive bladder after surgery—preoperative OAB symptom score, dyslipidemia, and non-nerve-sparing technique (2025). Her research bridges surgical technique and patient-centered outcomes, providing actionable insights for preoperative counseling and postoperative management. With a growing citation impact, Honda‐Takinami is establishing herself as a key voice in functional urology and robotic surgery.